Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 61

1.

Crystal structure of K0.75[Fe(II) 3.75Fe(III) 1.25(HPO3)6]·0.5H2O, an open-framework iron phosphite with mixed-valent Fe(II)/Fe(III) ions.

Larrea ES, Mesa JL, Legarra E, Aguayo AT, Arriortua MI.

Acta Crystallogr E Crystallogr Commun. 2016 Jan 1;72(Pt 1):63-5. doi: 10.1107/S2056989015024007. eCollection 2016 Jan 1.

PMID:
26870587
2.

Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model.

Nistal-Villan E, Bunuales M, Poutou J, Gonzalez-Aparicio M, Bravo-Perez C, Quetglas JI, Carte B, Gonzalez-Aseguinolaza G, Prieto J, Larrea E, Hernandez-Alcoceba R.

Mol Cancer. 2015 Dec 16;14(1):210. doi: 10.1186/s12943-015-0479-x.

3.

Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance.

Zabaleta A, Riezu-Boj JI, Larrea E, Villanueva L, Lasarte JJ, Guruceaga E, Fisicaro P, Ezzikouri S, Missale G, Ferrari C, Benjelloun S, Prieto J, Sarobe P.

J Med Virol. 2015 Oct 8. doi: 10.1002/jmv.24399. [Epub ahead of print]

PMID:
26447929
4.

Assessment of β-lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB/c mice.

Moreno E, Schwartz J, Larrea E, Conde I, Font M, Sanmartín C, Irache JM, Espuelas S.

Nanomedicine. 2015 Nov;11(8):2003-12. doi: 10.1016/j.nano.2015.07.011. Epub 2015 Aug 15.

PMID:
26282379
5.

The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids.

Fernandez-Mercado M, Manterola L, Larrea E, Goicoechea I, Arestin M, Armesto M, Otaegui D, Lawrie CH.

J Cell Mol Med. 2015 Oct;19(10):2307-23. doi: 10.1111/jcmm.12625. Epub 2015 Jun 27. Review.

6.

Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection.

Zabaleta A, D'Avola D, Echeverria I, Llopiz D, Silva L, Villanueva L, Riezu-Boj JI, Larrea E, Pereboev A, Lasarte JJ, Rodriguez-Lago I, Iñarrairaegui M, Sangro B, Prieto J, Sarobe P.

Mol Ther Methods Clin Dev. 2015 Mar 11;2:15006. doi: 10.1038/mtm.2015.6. eCollection 2015.

7.

A RIG-I 2CARD-MAVS200 Chimeric Protein Reconstitutes IFN-β Induction and Antiviral Response in Models Deficient in Type I IFN Response.

Nistal-Villán E, Rodríguez-García E, Di Scala M, Ferrero-Laborda R, Olagüe C, Vales Á, Carte-Abad B, Crespo I, García-Sastre A, Prieto J, Larrea E, González-Aseguinolaza G.

J Innate Immun. 2015;7(5):466-81. doi: 10.1159/000375262. Epub 2015 May 5.

PMID:
25966783
8.

Crystal structure of (NH4)2[Fe(II) 5(HPO3)6], a new open-framework phosphite.

Berrocal T, Mesa JL, Larrea E, Arrieta JM.

Acta Crystallogr Sect E Struct Rep Online. 2014 Oct 8;70(Pt 11):309-11. doi: 10.1107/S1600536814021783. eCollection 2014 Nov 1.

9.

Heterogeneous catalytic properties of unprecedented μ-O-[FeTCPP]2 dimers (H2TCPP = meso-tetra(4-carboxyphenyl)porphyrin): an unusual superhyperfine EPR structure.

Fidalgo-Marijuan A, Barandika G, Bazán B, Urtiaga MK, Larrea ES, Iglesias M, Lezama L, Arriortua MI.

Dalton Trans. 2015 Jan 7;44(1):213-22. doi: 10.1039/c4dt02250e.

PMID:
25371170
10.

A quick and efficient method to generate mammalian stable cell lines based on a novel inducible alphavirus DNA/RNA layered system.

Aranda A, Bezunartea J, Casales E, Rodriguez-Madoz JR, Larrea E, Prieto J, Smerdou C.

Cell Mol Life Sci. 2014 Dec;71(23):4637-51. doi: 10.1007/s00018-014-1631-2. Epub 2014 May 3.

PMID:
24794511
11.

Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection.

Larrea E, Echeverria I, Riezu-Boj JI, Aldabe R, Guembe L, Sola I, Civeira MP, Sarobe P, Prieto J.

J Hepatol. 2014 Mar;60(3):482-9. doi: 10.1016/j.jhep.2013.10.016. Epub 2013 Oct 26.

PMID:
24418171
12.

Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes.

Lawrie CH, Larrea E, Larrinaga G, Goicoechea I, Arestin M, Fernandez-Mercado M, Hes O, Cáceres F, Manterola L, López JI.

J Pathol. 2014 Jan;232(1):32-42. doi: 10.1002/path.4296.

PMID:
24155122
13.

Usage of adenovirus expressing thymidine kinase mediated hepatocellular damage for enabling mouse liver repopulation with allogenic or xenogenic hepatocytes.

Moreno D, Balasiddaiah A, Lamas O, Duret C, Neri L, Guembe L, Galarraga M, Larrea E, Daujat-Chavanieu M, Muntane J, Maurel P, Riezu JI, Prieto J, Aldabe R.

PLoS One. 2013 Sep 24;8(9):e74948. doi: 10.1371/journal.pone.0074948. eCollection 2013.

14.

Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes.

Larrea E, Riezu-Boj JI, Aldabe R, Guembe L, Echeverria I, Balasiddaiah A, Gastaminza P, Civeira MP, Sarobe P, Prieto J.

Gut. 2014 Apr;63(4):665-73. doi: 10.1136/gutjnl-2012-304377. Epub 2013 Jun 20.

PMID:
23787026
15.

A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.

Sangro B, Gomez-Martin C, de la Mata M, Iñarrairaegui M, Garralda E, Barrera P, Riezu-Boj JI, Larrea E, Alfaro C, Sarobe P, Lasarte JJ, Pérez-Gracia JL, Melero I, Prieto J.

J Hepatol. 2013 Jul;59(1):81-8. doi: 10.1016/j.jhep.2013.02.022. Epub 2013 Mar 4.

PMID:
23466307
16.

Thermal response, catalytic activity, and color change of the first hybrid vanadate containing Bpe guest molecules.

Fernández de Luis R, Urtiaga MK, Mesa JL, Larrea ES, Iglesias M, Rojo T, Arriortua MI.

Inorg Chem. 2013 Mar 4;52(5):2615-26. doi: 10.1021/ic302662x. Epub 2013 Feb 14.

PMID:
23409737
17.

Validation of an antiviral assay method for quantifying IFN-α5 activity in macaque and human serum.

Arbillaga L, Murillo-Arbizu M, González I, Gil AG, Vettorazzi A, González-Peñas E, Larrea E, de Cerain AL.

Bioanalysis. 2013 Feb;5(3):289-305. doi: 10.4155/bio.12.313.

PMID:
23394696
18.

Amine templated open-framework vanadium(III) phosphites with catalytic properties.

Orive J, Larrea ES, Fernández de Luis R, Iglesias M, Mesa JL, Rojo T, Arriortua MI.

Dalton Trans. 2013 Apr 7;42(13):4500-12. doi: 10.1039/c2dt32286b.

PMID:
23340960
19.

Synthesis and comparative study of Co(pym)(VO3)2 and [Co(H2O)2(VO3)2]·2H2O.

Larrea ES, Mesa JL, Pizarro JL, Fernández de Luis R, Rodríguez Fernández J, Rojo T, Arriortua MI.

Dalton Trans. 2012 Dec 14;41(46):14170-9. doi: 10.1039/c2dt31531a. Epub 2012 Oct 4.

PMID:
23034532
20.

CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy.

Hervas-Stubbs S, Mancheño U, Riezu-Boj JI, Larraga A, Ochoa MC, Alignani D, Alfaro C, Morales-Kastresana A, Gonzalez I, Larrea E, Pircher H, Le Bon A, Lopez-Picazo JM, Martín-Algarra S, Prieto J, Melero I.

J Immunol. 2012 Oct 1;189(7):3299-310. Epub 2012 Aug 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk